午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Shanghai Yifei Biotechnology Co. , Ltd.

Firmenname:Shanghai Yifei Biotechnology Co. , Ltd.
Telefon:021-65675885
E-Mail:customer_service@efebio.com
Nationalit?t:China
URL: http://www.efebio.com
Produkte insgesamt:11974
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

Produktkatalog

Felzartamab2197112-39-1
CCCI-01215778-97-5C11H9N3O4
Zanidatamab2169946-15-8
Amivantamab2171511-58-1
Axatilimab2155851-88-8
Zelminemab2225850-33-7
Glucocorticoid receptor agonist-12166375-82-0C35H39NO6
Nec-34i2212541-00-7C21H19N3O2S
RO71858762226038-71-5C25H28F3N7
IRAK4-IN-212170694-04-7C28H28FN7O2
Tau-aggregation and neuroinflammation-IN-12175953-98-5C25H20N2O7
MMV6888452208962-35-8C24H25N3O3S
TZ3O2218754-19-7C18H13NO4S
(S)-Desmethyl-NNC112221132-62-3C18H16ClNO2
Sibrotuzumab216669-97-5
2'-O-(2-Azidoethyl)adenosine2226475-42-7C12H16N8O4
Relfovetmab2171034-70-9
Disitamab2185868-98-6
Sasanlimab2206792-50-7
Tinurilimab2226224-30-0
SHP2-IN-6 hydrochloride2169223-49-6C22H27ClF2N6O2S
MI-3892222635-92-7C35H35FN6O6
Ruplizumab220651-94-5
Visilizumab219716-33-3
RO0270608220846-33-3C24H19Cl3N2O4
LTβR-IN-12189366-77-4C18H16N4O2
Nidanilimab2171061-85-9
Cosibelimab2216751-26-5
MY33-32204280-41-9C16H13F6NS2
AZD81542215022-45-8C27H29N5O4S2
Navocaftor2159103-66-7C15H11F3N4O5S
Gemnelatinib2225123-30-6C30H29FN6O2
(S,R,S)-AHPC-CO-C9-acid2172819-78-0C33H48N4O6S
INCB-0009282173389-57-4C30H38N4O3
Zagociguat2201048-82-8C16H10F4N6
ATG7-IN-22226227-75-2C11H16N6O7S
Pexelizumab219685-93-5
Metronidazole-hydroxy-d22196180-19-3C6H9N3O4
AKOS0376522562171065-77-1C24H26ClFN4O4S2
Lacutamab2187368-16-5
Batoclimab2187430-05-1
PSMA I&T2192281-54-0C63H92IN11O23
NV-54402226614-88-4C31 H36 N6 O3 S
MY102204270-73-3C15H10F6OS2
Tuberculosis inhibitor 32219325-28-5C21H22F6N4O3S
K-111221564-97-2C18H25Cl3O2
Ragifilimab2207590-51-8
(S)-HH28532202678-05-3C31H36F3N7O3
Benproperine2156-27-6C21H27NO
Chst15-IN-12158198-77-5C17H11BrCl2N2O3
Garadacimab2162134-62-3
Avdoralimab2226393-85-5
Nurulimab2168561-20-2
Crobenetine221019-25-6C25H33NO2
L 756423216863-66-0C39H48N4O5
Benzyl-PEG12-alcohol2218463-17-1C31H56O13
4,4-Diphenylbutylamine hydrochloride22101-90-2C16H20ClN
Indole-C2-amide-C2-NH2215789-29-0C13H17N3O
SARS-CoV-2-IN-1422203-98-1C13H9Cl2NO2
SOCE inhibitor 12169316-15-6C25H22F3N5O4
Semorinemab2159141-27-0
Dovanvetmab2171034-71-0
Tafolecimab2225109-03-3
Thalidomide-O-C6-COOH2169266-69-5C20H22N2O7
DBCO-PEG3-NHS ester2163772-16-3C32H35N3O9
MY33-3 hydrochloride2204280-42-0C16H14ClF6NS2
Propionanilide, 3'-hydroxy-21556-86-5C9H11NO2
Astegolimab2173054-79-8
Befovacimab2156634-62-5
SCH 57790221660-80-6C25H31N3O2S
L-796,778217480-25-6C29H40N6O7
ALDH1A2-IN-12204229-64-9C21H26N4O4S
Mal-amide-PEG8-Val-Ala-PAB-PNP2210247-59-7C48H68N6O19
(R)-HH28532202678-06-4C31H36F3N7O3
PARP10-IN-32225800-19-9C14H12N2O3
Mitumomab216503-58-1
Labetuzumab219649-07-7
Monuron-d6217488-65-8C9H11ClN2O
Lenalidomide-PEG1-azide2185795-67-7C17H18N6O5
Magrolimab2169232-81-7
Manelimab2168561-26-8
Atinvicitinib2169273-59-8C16H17FN6O3
IRAK4-IN-222170694-05-8C28H28FN7O2
Bamocaftor2204245-48-5C28H32F3N5O4S
Simazine-d5220621-41-0C7H12ClN5
TLR7 agonist 12178156-33-5C21H25N5O
Bedinvetmab2171034-69-6
Encelimab2173096-82-5
Arg-Gly-Asp-Cys TFA2171504-22-4C17H28F3N7O9S
TLR7/8-IN-12205095-75-4C29H40N8O2
Cytembena21739-91-3C11H9BrO4.Na
Elsibucol216167-95-2C35H54O4S2
Pramiconazole219923-85-0C35H39F2N7O4
Sonlicromanol hydrochloride2162149-24-6C19H29ClN2O3
KDM2A/7A-IN-12169272-46-0C33H38N4O
IL-17A antagonist 12205034-18-8C33H41FN6O4
Petosemtamab2213450-26-9
Talquetamab2226212-40-2
AVG-2332151937-80-1C26H22ClN5O3
(R)-GSK-36850322170140-50-6C22H24N6OS
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2019 ? ChemicalBook. All rights reserved